Added to YB: 2026-02-12
Pitch date: 2026-02-10
COLO-B.CO [neutral]
Coloplast A/S
-1.3%
current return
Author Info
Lux Opes Research covers European companies. Lots of them. Sign up for the newsletter.
Company Info
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally.
Market Cap
DKK 108.3B
Pitch Price
DKK 486.00
Price Target
N/A
Dividend
4.78%
EV/EBITDA
14.91
P/E
27.18
EV/Sales
4.74
Sector
Health Care Equipment and Supplies
Category
N/A
Coloplast (COLOB Denmark): a soft start puts pressure on credibility
COLO-B.CO (update): Q1 miss w/ organic growth 6% (in line) but EBIT DKK 1.92bn at 26.7% margin below expectations. China weakness pressures Ostomy (-) & Wound Care. Interventional Urology +8% standout. FY guidance reiterated: ~7% organic rev & EBIT growth, ~28% margin. Credibility strained after series of resets; needs cleaner execution to rebuild confidence.
Read full article (2 min)